D. Kim Turgeon

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

Kenneth S. Lown, Robert R. Mayo, Alan B. Leichtman et al. · Clinical Pharmacology & Therapeutics · 1997 · 682 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

Frank L. Meyskens, Christine E. McLaren, Daniel Pelot et al. · Cancer Prevention Research · 2008 · 519 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

Robert E. Carroll, Richard V. Benya, D. Kim Turgeon et al. · Cancer Prevention Research · 2011 · 491 citations · Full text

Medicine, Oncology, Pharmacology +15

Plasma Glycoprotein Profiling for Colorectal Cancer Biomarker Identification by Lectin Glycoarray and Lectin Blot

Yinghua Qiu, Tasneem H. Patwa, Li Xu et al. · Journal of Proteome Research · 2008 · 192 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results

Matthew B. Sturm, Bishnu Joshi, Shaoying Lu et al. · Science Translational Medicine · 2013 · 176 citations

Medicine, Biomedical Engineering, Oncology +16